Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,800 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Cancer Medicine, 2025Direct Oral Anticoagulants Are Comparable to Low Molecular Weight Heparin at Sustaining the Circulating Extracellular Vesicle and Inflammatory Profiles of Cancer Associated Thrombosis Patients: An Observational Pilot Study
Macleod H., Copty N., Doherty D. et al.
Olink Target 48
Alzheimer's & Dementia, 2025Exploring inflammation‐related protein expression and its relationship with TSPO PET in Alzheimer's disease
Pola I., Ashton N., Antônio De Bastiani M. et al.
Olink Explore 3072/384
Nature Communications, 2025Dissecting cross-population polygenic heterogeneity across respiratory and cardiometabolic diseases
Yamamoto Y., Shirai Y., Sonehara K. et al.
Frontiers in Medicine, 2025Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure mice
Baker J., Daly L., Hassibi S. et al.
Olink Target 96
hLife, 2025Systemic profiling of immune responses in healthy adults vaccinated with an RBD-targeting COVID-19 mRNA vaccine
Zhou C., Sun M., Huang X. et al.
npj Aging, 2025Genetic determinants of proteomic aging
Mörseburg A., Zhao Y., Kentistou K. et al.
World Journal of Surgical Oncology, 2025Causal effect of gut microbiota on the risk of cancer and potential mediation by inflammatory proteins
Wang Y., Liu W., Liu L. et al.
eBioMedicine, 2025Quantifying temporal differences in the induction of interferon-mediated signalling observed in a dengue virus 1 human infection model: insights from longitudinal proteome analysis
Struyfs C., Van den Heede K., Van Wesenbeeck L. et al.
Olink Flex
Brain, 2025Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination
Abdelhak A., Cordano C., Duncan G. et al.
International Journal of Molecular Sciences, 2025Significant Associations Between Blood Cell Counts and Plasma Cytokines, Chemokines, and Growth Factors
Eriksson L., Eriksson M., Gordh T. et al.
Cell Reports Medicine, 2025Cooking methods affect advanced glycation end products and lipid profiles: A randomized cross-over study in healthy subjects
Wellens J., Vissers E., Dumoulin A. et al.
Nature Communications, 2025Targeted plasma proteomics reveals organ damage signatures of AIDS- and noncommunicable disease-related deaths in people with HIV
Lin H., He J., Ren J. et al.
Communications Medicine, 2025Proteomics approach identifies aqueous humor biomarkers in retinal diseases
Huang K., Schofield C., Nguy T. et al.
European Heart Journal, 2025Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial
Berger M., MacNamara A., Ferreira J. et al.
Annals of Allergy, Asthma & Immunology, 2025Proteomic Profiling of Nasal Fluids and Serum for Type 2 Nasal Polyps Diagnosis
Hou Y., Chen C., Li Z. et al.
Journal for ImmunoTherapy of Cancer, 2025Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial treated with immunotherapy, chemotherapy, or chemoimmunotherapy
Toney N., Lynch M., Lynce F. et al.
Translational Stroke Research, 2025Proteomic and Demographic Comparisons of Recurrent Ischemic Stroke Patients
Meredith N., Harp J., McLouth C. et al.
Angiogenesis, 2025ApoM-bound S1P acts via endothelial S1PR1 to suppress choroidal neovascularization and vascular leakage
Jung B., Yagi H., Kuo A. et al.
Parkinsonism & Related Disorders, 2025Plasma proteomic profiling reveals Parkinson's disease-associated proteins: A UK Biobank study
Jiao X., Lu Y., Huang Y. et al.
Diabetes Research and Clinical Practice, 2025Plasma proteomic signatures for type 2 diabetes and related traits in the UK Biobank cohort
Gupte T., Azizi Z., Kho P. et al.
3899 publications
Items per page
1221-1240 of 3899 publications